Sign in
Taking people in United StatesNo phase

Home use of the LibAirty airway clearance device in adults with bronchiectasis

Observes how often lung flare-ups happen in adults with bronchiectasis using LibAirty at home.

Key facts

Who runs it
Synchrony-Medical, Ltd
Where
Atlanta, Birmingham, and Charleston, United StatesSee the 3 sites
Trial code
Registry title
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
Status
Recruiting
People taking part
200 people, planned
Started
20 Aug 2025
Expected to end
Feb 2027
Type of study
Observational
Treatments tested
  • Airway clearance system
Record updated
13 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with bronchiectasis whose doctor has prescribed the LibAirty airway clearance system for home use. Bronchiectasis is a lung condition with widened airways.

Age
21 years and older.
Sex
All sexes can join.
Disease stage
Bronchiectasis seen on a high resolution chest CT scan. People must have a daily cough that brings up mucus, or 2 or more lung flare-ups needing antibiotics in the last 12 months.
Earlier treatment
People must be prescribed and receive the LibAirty system for home use. Their bronchiectasis treatment must not have changed in the 2 months before joining. They must see a doctor at least once every 6 months.

Main reasons for not taking part

  • People who cannot use the LibAirty system on their own as directed cannot join.
  • People who are pregnant or plan a pregnancy during the 12 months of the trial cannot join.
  • People with any other condition the study doctor thinks could harm their safety or affect the results cannot join.

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Have a radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
  • Have bronchiectasis characterized by either:; Daily productive cough (as determined by a treating physician); OR Available documentation from the last 12 months of 2 or more pulmonary exacerbations requiring antibiotic therapy
  • Be at age ≥ 21 years
  • Prescribed and receives the LibAirty system for home use
  • Be on a standard of care treatment plan that includes at least one physician encounter every 6 months
  • No change in treatment for Bronchiectasis in the 2-month period prior to enrollment
  • Signed informed consent

Who cannot take part

  • Inability to independently perform therapy with the LibAirty system as directed
  • Any other condition that, in the opinion of the PI, could jeopardize the safety of the subject or impact the validity of the study results
  • Pregnancy or planned pregnancy during the expected duration of the trial (12 months)

Where in United States

  • Emory University School of MedicineAtlanta, United StatesContact: Study CoordinatorTaking people
  • University of Alabama at BirminghamBirmingham, United StatesContact: Clinical Research CordinatorTaking people
  • Medical University of South CarolinaCharleston, United StatesContact: Study CoordinatorTaking people

About the trial

What the trial wants to find out

The purpose of this study is to collect data to assess the use of the LibAirty™ System for improving bronchiectasis symptoms and healthcare resource utilization when it is used at home.

Read full original descriptionShow less

The main question this study is trying to answer is: How often do adults with bronchiectasis experience pulmonary exacerbations (flare-ups of their lung condition) while using the LibAirty™ airway clearance system at home?

Participants will use the LibAirty™ airway clearance system at home as prescribed by their doctor - the device is not being provided as part of the study. The study will last for 12 months from the time participants begin using LibAirty.

During the study period, participants will continue with their usual clinic visits. At some of these regular visits (up to 4 times over the year), participants will be asked to complete short questionnaires about their bronchiectasis symptoms and their experience using LibAirty. At these same visits, the study team will also review participants' medical records and collect information related to their bronchiectasis condition, such as test results, medications, and any hospital or emergency room visits.

The group in the trial

  • Adults with bronchiectasis

    Adults with bronchiectasis, prescribed with the LibAirty airway clearance system

    Treatment: Airway clearance system

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS) - A Prospective Study
Plain-language title
Home use of the LibAirty airway clearance device in adults with bronchiectasisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
13 April 2026